Publications

Journal Article
Review
Epublish 224 citations
Electronic publication date
November 13, 2021

View on Pubmed.gov 34766135 | View on doi.org 10.1002/mco2.27

Lipid metabolism in cancer progression and therapeutic strategies.

Search for publications in this journal MedComm (2020) - 2(1):27-59

Abstract

Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, storage, and uptake of lipids contribute to cancer progression. The rewiring of lipid metabolism in cancer has been linked to the activation of oncogenic signaling pathways and cross talk with the tumor microenvironment. The resulting activity favors the survival and proliferation of tumor cells in the harsh conditions within the tumor. Lipid metabolism also plays a vital role in tumor immunogenicity via effects on the function of the noncancer cells within the tumor microenvironment, especially immune-associated cells. Targeting altered lipid metabolism pathways has shown potential as a promising anticancer therapy. Here, we review recent evidence implicating the contribution of lipid metabolic reprogramming in cancer to cancer progression, and discuss the molecular mechanisms underlying lipid metabolism rewiring in cancer, and potential therapeutic strategies directed toward lipid metabolism in cancer. This review sheds new light to fully understanding of the role of lipid metabolic reprogramming in the context of cancer and provides valuable clues on therapeutic strategies targeting lipid metabolism in cancer.

References

Cancer Lett. 2017 Aug 10;401:39-45

Cell Metab. 2019 Apr 2;29(4):886-900.e5

Nat Med. 2016 Apr;22(4):427-32

Adv Biol Regul. 2016 Jan;60:151-159

Cited by 224 citations (total)

Journal Article Review

Lipid metabolism in cancer progression and therapeutic strategies.

Electronic publication date November 13, 2021

Search for publications in this journal MedComm (2020)

Yan Fu [...] Qiongzhu Dong et al.

Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent...

Journal Article

Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients.

Electronic publication date November 29, 2023

Search for publications in this journal Front Mol Biosci

Cindy Arévalo [...] Susana Fiorentino et al.

Acute leukemias (AL) are aggressive neoplasms with high mortality rates. Metabolomics and oxidative status have emerged as important tools to...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Copyright

© 2020 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.